openPR Logo
Press release

Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, NeRRe Therapeutics, Menlo Therapeutics, XBiotech, Ipsen Pharma, Novus Therapeutics

09-04-2019 08:56 AM CET | IT, New Media & Software

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Pruritus Drug Market types

Pruritus Drug Market types

The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report for various organizations, authorities, analysts, products and innovation advancement establishments who are quick to investigate the worldwide Pruritus Drug at a minute level. The report gives details about key drivers and restraints, the Pruritus Drug market size, industry share, CAGR values, growth details and key segments.

Global Pruritus Drug Market is growing at a substantial CAGR in the forecast period of 2019-2026. Increasing research and development expenses and high demand of novel therapies are some factors fueling the market growth.

Pruritus is referring to the severe itching associated with number of dermatological disorders including xerotic eczema, atopic dermatitis, and allergic contact dermatitis. It is typically an unpleasant sensation that elicits a desire to scratch vigorously and it is greatly altered by psychological and CNS factors.

According to the statistics published in U.S. Department of Health and Human Services, it was estimated approximately 10 to 25% people were affected with pruritus worldwide. Huge financial support from the government and increase in strategic alliances between the companies are key factors for market growth.

Request for Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-pruritus-drug-market

Market Drivers

Increase prevalence of pruritus worldwide is driving the market growth
Increase special designation from the regulatory authorities is boosting the market growth
High specific demand of novel treatment is accelerating the market growth
Huge financial support to the researchers for developing novel intervention is enhancing the market growth
Segmentation: Global Pruritus Drug Market

By Indication

Chronic Kidney Disease associated Pruritus
Chronic Liver Disease associated Pruritus
Atopic Dermatitis Associated Pruritus
Others
By Drugs

Corticosteroids
Antihistamines
Counterirritants
Others
By Routes of Administration

Injectable
Topical
Oral
By End Users

Hospitals
Homecare
Specialty Clinics
Others
By Distribution Channel

Hospital Pharmacy
Online Pharmacy
Retailers
Others
By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa
Browse Full Report with Details TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-pruritus-drug-market

Key Developments in the Market:

In August 2019, Cara Therapeutics in-licensed exclusive worldwide excluding South Korea and Japan to develop and commercialize oral Korsuva, selective inhibitor of kappa opioid receptors from Enteris BioPharma for the treatment of chronic pruritus. Under the deal terms, Enteris BioPharma granted Cara Therapeutics Peptelligence Technology to develop and commercialize Oral Korsuva in any indication. Enteris BioPharma will receive an upfront payment of USD 8.00 million comprised of USD 4.00 million in cash. Additionally, Enteris BioPharma is eligible to receive development, regulatory and tiered commercial milestone payments, as well as low, single-digit royalties based on net sales in the licensed territory granted by Enteris BioPharma.

In January 2019, Menlo Therapeutics received Breakthrough Therapy designation from the FDA for serlopitant, an oral NK1 receptor antagonist for the treatment of pruritus associated with Prurigo Nodularis (PN). The FDA’s Breakthrough Therapy designation expedites development and timeline process and facilitates FDA regular interaction and guidance which will make regulatory approval faster and hence help patients suffering from pruritus to regulatory approval faster.

Competitive Analysis:

Global pruritus drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global pruritus drug market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global pruritus drug market are Cara Therapeutics, Enteris BioPharma, NeRRe Therapeutics, Menlo Therapeutics, XBiotech, Ipsen Pharma, Novus Therapeutics, Inc, AMOREPACIFIC CORPORATION, RDD Pharma, Ltd, Pfizer Inc and others.

Inquiry before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pruritus-drug-market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, NeRRe Therapeutics, Menlo Therapeutics, XBiotech, Ipsen Pharma, Novus Therapeutics here

News-ID: 1829554 • Views:

More Releases from Data Bridge Market Research

Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, …
"Preparative and Process Chromatography Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis.
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Deman …
"Global Sodium Lactate Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand more information about industry competitors. Being the most suitable example of the above attributes, the
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Tren …
Data Bridge Market research has recently released expansive research titled Global Cold Chain Monitoring Components Market guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
The rise in demand for water treatment in industrial applications across the globe acts as one of the major factors driving the growth of sodium hypophosphite market. The rise in usage of sodium hypophosphite in the electroplating application as reducing agents, and increase in electroplating of metal surface assist in enhancing properties such as abrasion resistance, hardness, corrosion resistance, and strength among others accelerate the market growth. The increase in

All 5 Releases


More Releases for Pruritus

Pruritus Drugs Market Future Innovation Strategies 2028
Global Pruritus Drugs Market: Overview Transdermal drug delivery system is the most preferred way to inject pruritus drugs. Most of the pruritus drugs that are available in the market are in the semi-solid topical dosage state. It includes forms such as creams, gels, and lotions. These products are quite easy to apply, give no or less pain, and are quicker in terms of delivering desired effect as compared to other drug
Pruritus Drugs Market to Witness Robust Expansion by 2025
Market Research Report Store offers a latest published report on Pruritus Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Pruritus Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Pruritus Drugs with respect to individual growth
Pruritus Therapeutics Market Share 2018-2026 Segmented by Top Companies like: Pr …
“Pruritus Therapeutics Market [By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others); By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others); By Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa - UAE, Saudi Arabia, South Africa)]: Market size & Forecast, 2017 – 2026” Polaris Market Research’s
Pruritus Therapeutics Industry – Treatment Analysis,Research,Review to 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Pruritus Therapeutics Industry – Treatment Analysis,Research,Review to 2022”. Description: The Pruritus Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Pruritus Therapeutics market size to maintain the average annual growth rate of 4.51% from 990 million $ in 2014 to 1130 million $ in 2017, The analysts believe that in the next few
Pruritus - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pruritus - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus - Pipeline Review, H2 2017, provides an overview of the Pruritus (Dermatology) pipeline landscape. Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments,
Global Pruritus Market Pipeline Review, H2 2017
"The Report Pruritus - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus - Pipeline Review, H2 2017, provides an overview of the Pruritus (Dermatology) pipeline landscape. Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments,